Rentschler: 4th Laupheim Biotech Days to take place 13–14 June 2016

Exciting lectures and discussions on therapeutic fusion proteins.

This conference with the title "Fusion Proteins - delivering novel therapeutic options" is focused on the state of the art in developing fusion proteins as biopharmaceuticals, shedding light on the immense potential of design and functionality.

Fusion proteins belong to the most lucrative biotech drugs. The highly diverse pipeline is constantly growing with more than 80 molecules in clinical trials and five newly approved molecules in 2014 alone. This dynamic growth is primarily driven by three trends: Establishing platform technologies to extend plasma half-life, innovative approaches addressing multiple targets simultaneously and novel toxic constructs with superior selectivity. Therefore, it is worthwhile to dedicate a closer look to this exciting class of therapeutics.

A highlight of the event are the presentations by international speakers. Topics are among others toxic constructs, antibody derived molecules and bispecific scaffolds. At the first conference day, you will have the opportunity to participate at a tour of Rentschler’s facility. There will be also an industrial exhibition with companies showing their innovations and services. The deadline to register is 13 May 2016.